胚胎移植前宫腔内注射人绒毛膜促性腺激素可改善体外受精-胚胎移植结局:随机对照试验的Meta分析
该Meta分析纳入15项随机对照试验共2763例不孕女性,比较胚胎移植前宫腔内注射人绒毛膜促性腺激素与安慰剂或不注射对体外受精-胚胎移植结局的影响。结果显示实验组活产率、持续妊娠率、临床妊娠率和着床率均显著高于对照组,流产率显著低于对照组。作者认为不同给药时机和剂量可能产生不同效应,移植前15分钟内给予500 IU人绒毛膜促性腺激素可获得最佳结局。
要点
- 移植前宫腔内注射人绒毛膜促性腺激素可提高活产率、持续妊娠率、临床妊娠率和着床率。
- 移植前宫腔内注射人绒毛膜促性腺激素可降低流产率。
- 不同给药时机和剂量可能影响结局,移植前15分钟内给500 IU可获得最佳结局。
核心结论
- 该Meta分析结果表明,胚胎移植前宫腔内注射人绒毛膜促性腺激素可改善体外受精-胚胎移植后的活产率、持续妊娠率、临床妊娠率和着床率。
- 不同给药时机和剂量的人绒毛膜促性腺激素可能对体外受精-胚胎移植结局产生不同影响。
- 移植前15分钟内给予500 IU人绒毛膜促性腺激素的不孕女性可获得最佳体外受精-胚胎移植结局。
研究设计与样本
- 研究设计为Meta分析,纳入15项随机对照试验,共2763例参与者。
- 研究对象为接受体外受精-胚胎移植并在移植前接受宫腔内人绒毛膜促性腺激素注射的不孕女性。
- 干预为胚胎移植前宫腔内注射人绒毛膜促性腺激素,对照为宫腔内注射安慰剂或不注射。
主要发现
- 实验组活产率为44.89%,对照组为29.76%,实验组显著高于对照组。
- 实验组持续妊娠率为48.09%,对照组为33.42%,实验组显著高于对照组。
- 实验组临床妊娠率为47.80%,对照组为32.78%,实验组显著高于对照组。
- 实验组着床率为31.64%,对照组为22.52%,实验组显著高于对照组。
- 实验组流产率为12.45%,对照组为18.56%,实验组显著低于对照组。
关键数值与推荐
- 主要结局为活产率、持续妊娠率和临床妊娠率,次要结局为着床率和流产率。
- 合并优势比及其95%置信区间用于评估人绒毛膜促性腺激素对体外受精-胚胎移植结局的影响。
- 移植前15分钟内给予500 IU人绒毛膜促性腺激素可获得最佳体外受精-胚胎移植结局。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate whether intrauterine injection of hCG before embryo transfer can improve IVF-ET outcomes. DESIGN: Meta-analysis. SETTING: Not applicable. PATIENT(S): Infertile women who underwent IVF-ET and received an intrauterine injection of hCG before ET. INTERVENTION(S): Infertile women treated with or without intrauterine hCG injection before ET. MAIN OUTCOME MEASURE(S): The primary outcomes were live birth rate (LBR), ongoing pregnancy rate (OPR), and clinical pregnancy rate (CPR), and the secondary outcomes were implantation rate (IR) and miscarriage rate (MR). Odds ratios with 95% confidence intervals (CIs) and successful ET rates were pooled to determine the effects of hCG on IVF-ET outcomes. RESULT(S): Fifteen randomized controlled trials (RCTs) with a total of 2,763 participants were included. Infertile women in the experimental group (treated with intrauterine hCG injection before ET) exhibited significantly higher LBR (44.89% vs. 29.76%), OPR (48.09% vs. 33.42%), CPR (47.80% vs. 32.78%), and IR (31.64% vs. 22.52%) than those in the control group (intrauterine injection of placebo or no injection). Furthermore, MR was significantly lower (12.45% vs. 18.56%) in the experimental group than in the control group. CONCLUSION(S): The findings of this meta-analysis indicate that intrauterine injection of hCG can improve LBR, OPR, CPR, and IR after IVF-ET cycles. In addition, different timing and dosages of hCG administration may exert different effects on IVT-ET outcomes. Notably, infertile women treated with 500 IU hCG within 15 minutes before ET can achieve optimal IVF-ET outcomes.
引用
- Gao M, Jiang X, Li B, et al. Intrauterine injection of human chorionic gonadotropin before embryo transfer can improve in vitro fertilization-embryo transfer outcomes: a meta-analysis of randomized controlled trials. Fertil Steril. 2019. PMID: 31277770. doi:10.1016/j.fertnstert.2019.02.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。